{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:54:13Z","timestamp":1791089653976,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.sleep.2026.109154","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:15:47Z","timestamp":1785482147000},"page":"109154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacological treatments of REM sleep behaviour disorder in synucleinopathies: a systematic review of effectiveness and safety"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7157-946X","authenticated-orcid":false,"given":"Jess J.","family":"Byun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vellingiri Raja","family":"Badrakalimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.sleep.2026.109154_bib1","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1001\/jama.1987.03390130104038","article-title":"Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults","volume":"257","author":"Schenck","year":"1987","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.sleep.2026.109154_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/09540260500104540","article-title":"REM sleep behaviour disorder: clinical profiles and pathophysiology","volume":"17","author":"Paparrigopoulos","year":"2005","journal-title":"Int Rev Psychiatr"},{"issue":"1","key":"10.1016\/j.sleep.2026.109154_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5665\/sleep.5332","article-title":"The clinical phenotype of idiopathic rapid eye movement sleep behavior disorder at presentation: a study in 203 consecutive patients","volume":"39","author":"Fern\u00e1ndez-Arcos","year":"2016","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2026.109154_bib4","series-title":"Rapid-eye-movement sleep behavior disorder","article-title":"Differential diagnosis and related disorders: RBD mimics","author":"Manni","year":"2019"},{"issue":"1","key":"10.1016\/j.sleep.2026.109154_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5664\/jcsm.27717","article-title":"Best practice guide for the treatment of REM sleep behavior disorder (RBD)","volume":"6","author":"Aurora","year":"2010","journal-title":"J Clin Sleep Med"},{"issue":"8","key":"10.1016\/j.sleep.2026.109154_bib6","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.clinph.2018.05.003","article-title":"Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies","volume":"129","author":"Barone","year":"2018","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.sleep.2026.109154_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.smrv.2018.09.008","article-title":"The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies","volume":"43","author":"Galbiati","year":"2019","journal-title":"Sleep Med Rev"},{"issue":"1","key":"10.1016\/j.sleep.2026.109154_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","article-title":"Idiopathic REM sleep behaviour disorder and neurodegeneration: an update","volume":"14","author":"H\u00f6gl","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"10.1016\/j.sleep.2026.109154_bib9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.sleep.2013.02.016","article-title":"Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the international rapid eye movement sleep behavior disorder study group","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep Med"},{"issue":"5","key":"10.1016\/j.sleep.2026.109154_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","article-title":"Neurodegenerative disease status and post-mortem pathology in idiopathic REM sleep behaviour disorder: an observational cohort study","volume":"12","author":"Iranzo","year":"2013","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.sleep.2026.109154_bib11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/brain\/awz030","article-title":"Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study","volume":"142","author":"Postuma","year":"2019","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.sleep.2026.109154_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1474-4422(20)30449-X","article-title":"Detection of \u03b1-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study","volume":"20","author":"Iranzo","year":"2021","journal-title":"Lancet Neurol"},{"issue":"18","key":"10.1016\/j.sleep.2026.109154_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207147","article-title":"Misfolded \u03b1-Synuclein assessment in the skin and CSF by RT-QuIC in isolated REM sleep behavior disorder","volume":"100","author":"Iranzo","year":"2023","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.sleep.2026.109154_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/WAD.0b013e3181b5065d","article-title":"Cognitive and neuropsychiatric profile of the synucleinopathies: parkinson disease, dementia with Lewy bodies, and multiple system atrophy","volume":"23","author":"Kao","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"10.1016\/j.sleep.2026.109154_bib15","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/acn3.756","article-title":"Plasma \u03b1-synuclein levels are increased in patients with obstructive sleep apnea syndrome","volume":"6","author":"Sun","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.sleep.2026.109154_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fneur.2019.00363","article-title":"Autonomic dysfunction in \u03b1-synucleinopathies","volume":"10","author":"Mendoza-Vel\u00e1squez","year":"2019","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.sleep.2026.109154_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/cjn.2019.287","article-title":"Falls in synucleinopathies","volume":"47","author":"Joza","year":"2020","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.sleep.2026.109154_bib18","doi-asserted-by":"crossref","DOI":"10.17241\/smr.2024.02201","article-title":"Obstructive sleep apnea and \u03b1-synucleinopathies: nationwide analysis from south Korea's healthcare database","author":"Song","year":"2024","journal-title":"Sleep Med Res"},{"key":"10.1016\/j.sleep.2026.109154_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jns.2018.08.008","article-title":"Pharmacological treatment for REM sleep behavior disorder in Parkinson disease and related conditions: a scoping review","volume":"393","author":"de Almeida","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.sleep.2026.109154_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.709878","article-title":"Pharmacological interventions for REM sleep behavior disorder in Parkinson's disease: a systematic review","volume":"13","author":"Yan","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"10.1016\/j.sleep.2026.109154_bib21","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3390\/jpm11111204","article-title":"Current treatment options for REM sleep behaviour disorder","volume":"11","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2021","journal-title":"J Personalized Med"},{"issue":"12","key":"10.1016\/j.sleep.2026.109154_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047934","article-title":"Efficacy and safety of treatments for REM sleep behaviour disorder in Parkinson's disease: a systematic review and Bayesian network meta-analysis protocol","volume":"11","author":"Lin","year":"2021","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.sleep.2026.109154_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00415-020-10353-0","article-title":"A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebo-controlled trials","volume":"269","author":"Gilat","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2026.109154_bib24","article-title":"Pharmacological interventions targeting \u03b1-synuclein aggregation triggered REM sleep behavior disorder and early development of Parkinson's disease","volume":"153","author":"Du","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.sleep.2026.109154_bib25","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"10.1016\/j.sleep.2026.109154_bib26","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.sleep.2026.109154_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sleep.2026.109154_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2012.09.009","article-title":"An observational clinical and video-polysomnographic study of the effects of clonazepam in REM sleep behavior disorder","author":"Ferri","year":"2013","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.sleep.2026.109154_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1212\/01.wnl.0000168864.97813.e0","article-title":"Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD","volume":"65","author":"Iranzo","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2026.109154_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2015.12.020","article-title":"A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder","author":"Li","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2026.109154_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s11325-022-02572-8","article-title":"Comparative efficacy of prolonged-release melatonin versus clonazepam for isolated rapid eye movement sleep behavior disorder","author":"Byun","year":"2023","journal-title":"Sleep Breath"},{"issue":"2","key":"10.1016\/j.sleep.2026.109154_bib33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mds.27886","article-title":"Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: a randomised controlled trial","volume":"35","author":"Gilat","year":"2020","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.sleep.2026.109154_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12759","article-title":"Treatment of isolated REM sleep behavior disorder using melatonin as a chronobiotic","volume":"71","author":"Kunz","year":"2021","journal-title":"J Pineal Res"},{"issue":"4","key":"10.1016\/j.sleep.2026.109154_bib34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/acn3.753","article-title":"Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder","volume":"6","author":"Jun","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"10.1016\/j.sleep.2026.109154_bib36","first-page":"1418","article-title":"Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease","volume":"31","author":"Kumru","year":"2008","journal-title":"Sleep"},{"issue":"10","key":"10.1016\/j.sleep.2026.109154_bib37","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1212\/WNL.61.10.1418","article-title":"The effects of pramipexole in REM sleep behaviour disorder","volume":"61","author":"Fantini","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.sleep.2026.109154_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.parkreldis.2012.08.010","article-title":"Factors associated with the effect of pramipexole on symptoms of idiopathic REM sleep behavior disorder","volume":"19","author":"Sasai","year":"2013","journal-title":"Parkinsonism Relat Disorders"},{"issue":"7","key":"10.1016\/j.sleep.2026.109154_bib39","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/mds.28577","article-title":"Cannabidiol for rapid eye movement sleep behavior disorder","volume":"36","author":"de Almeida","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2026.109154_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2021.02.038","article-title":"Nelotanserin as symptomatic treatment for rapid eye movement sleep behavior disorder: a double-blind randomized study using video analysis in patients with dementia with Lewy bodies or Parkinson's disease dementia","author":"Stefani","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2026.109154_bib41","doi-asserted-by":"crossref","DOI":"10.5664\/jcsm.5796","article-title":"An open-labeled trial of ramelteon in idiopathic rapid eye movement sleep behavior disorder","author":"Esaki","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2026.109154_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/mds.24909","article-title":"Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease","author":"Di Giacopo","year":"2012","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.sleep.2026.109154_bib43","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.5664\/jcsm.6200","article-title":"Effects of rotigotine on REM sleep behavior disorder in Parkinson disease","volume":"12","author":"Wang","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2026.109154_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad103","article-title":"Sodium oxybate in treatment-resistant rapid-eye-movement sleep behavior disorder","author":"During","year":"2023","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2026.109154_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jocn.2021.07.011","article-title":"Effects of safinamide on REM sleep behavior disorder in Parkinson disease: a randomized, longitudinal, cross-over pilot study","volume":"91","author":"Plastino","year":"2021","journal-title":"J Clin Neurosci"},{"issue":"3","key":"10.1016\/j.sleep.2026.109154_bib45","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s11325-021-02417-w","article-title":"Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease","volume":"26","author":"Meloni","year":"2022","journal-title":"Sleep Breath"},{"issue":"11","key":"10.1016\/j.sleep.2026.109154_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11940-016-0433-2","article-title":"Treatment of REM sleep behavior disorder","volume":"18","author":"Jung","year":"2016","journal-title":"Curr Treat Options Neurol"},{"issue":"9","key":"10.1016\/j.sleep.2026.109154_bib47","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1176\/ajp.146.9.1166","article-title":"A polysomnographic and clinical report on sleep-related injury in 100 adult patients","volume":"146","author":"Schenck","year":"1989","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.sleep.2026.109154_bib48","first-page":"S9","article-title":"Polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients","volume":"57","author":"Schenck","year":"1990","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"10.1016\/j.sleep.2026.109154_bib49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0002-9343(97)89493-4","article-title":"Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults","volume":"100","author":"Schenck","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.sleep.2026.109154_bib50","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3389\/fneur.2020.00610","article-title":"A neurologist's guide to REM sleep behavior disorder","volume":"11","author":"Roguski","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.sleep.2026.109154_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.04.029","article-title":"Clonazepam for probable REM sleep behavior disorder in Parkinson's disease: a randomized placebo-controlled trial","author":"Shin","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.sleep.2026.109154_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-022-06188-4","article-title":"Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson's disease and sleep disorders: a randomized, double-blind trial","author":"Hadi","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.sleep.2026.109154_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2012.09.018","article-title":"Treatment outcomes in REM sleep behavior disorder","author":"McCarter","year":"2013","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2026.109154_bib54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S1041610203009621","article-title":"Drug treatment of REM sleep behavior disorders in dementia with Lewy bodies","volume":"15","author":"Massironi","year":"2003","journal-title":"Int Psychogeriatr"},{"issue":"Suppl 2","key":"10.1016\/j.sleep.2026.109154_bib55","first-page":"9","article-title":"The effects of benzodiazepines on cognition","volume":"66","author":"Stewart","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"47","key":"10.1016\/j.sleep.2026.109154_bib56","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","article-title":"Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits","volume":"331","author":"Glass","year":"2005","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.sleep.2026.109154_bib57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5664\/jcsm.27492","article-title":"Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam","volume":"5","author":"Anderson","year":"2009","journal-title":"J Clin Sleep Med"},{"issue":"12","key":"10.1016\/j.sleep.2026.109154_bib58","first-page":"26","article-title":"[Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam]","volume":"112","author":"Litvinenko","year":"2012","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"6 Pt 2","key":"10.1016\/j.sleep.2026.109154_bib59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.17116\/jnevro20151156240-43","article-title":"[Melatonin in correction of REM-sleep behavior disorders in Parkinson's disease]","volume":"115","author":"Lyashenko","year":"2015","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"4","key":"10.1016\/j.sleep.2026.109154_bib60","doi-asserted-by":"crossref","first-page":"655","DOI":"10.5664\/jcsm.8308","article-title":"Use of clonazepam in REM sleep behavior disorder: association with fall-related injuries and alternative treatments","volume":"16","author":"Dokkedal-Silva","year":"2020","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2026.109154_bib61","first-page":"211","article-title":"Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations","volume":"36","author":"Kunz","year":"1997","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1016\/j.sleep.2026.109154_bib62","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1440-1819.2001.00854.x","article-title":"Melatonin therapy for REM sleep behavior disorder","volume":"55","author":"Takeuchi","year":"2001","journal-title":"Psychiatr Clin Neurosci"},{"issue":"4","key":"10.1016\/j.sleep.2026.109154_bib63","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1389-9457(03)00072-8","article-title":"Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients","volume":"4","author":"Boeve","year":"2003","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2026.109154_bib64","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2869.2010.00848.x","article-title":"A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder","volume":"19","author":"Kunz","year":"2010","journal-title":"J Sleep Res"},{"issue":"5","key":"10.1016\/j.sleep.2026.109154_bib65","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.sleep.2005.04.004","article-title":"Melatonin for sleep disturbances in Parkinson's disease","volume":"6","author":"Dowling","year":"2005","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2026.109154_bib66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00415-006-0390-x","article-title":"Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study","volume":"254","author":"Medeiros","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2026.109154_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2020.03.029","article-title":"Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: a randomized trial","author":"Ahn","year":"2020","journal-title":"Parkinsonism Relat Disorders"},{"key":"10.1016\/j.sleep.2026.109154_bib68","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.sleep.2024.10.020","article-title":"Melatonin on sleep in Parkinson's disease: a randomized double blind placebo controlled trial","volume":"124","author":"Sugumaran","year":"2024","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2026.109154_bib69","doi-asserted-by":"crossref","DOI":"10.1111\/jcpt.12179","article-title":"Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series","author":"Chagas","year":"2014","journal-title":"J Clin Pharm Therapeut"},{"issue":"7","key":"10.1016\/j.sleep.2026.109154_bib70","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.5664\/jcsm.11704","article-title":"The use of cannabinoid therapy in treatment-refractory isolated REM sleep behavior disorder: a case report","volume":"21","author":"Samra","year":"2025","journal-title":"J Clin Sleep Med"},{"issue":"18","key":"10.1016\/j.sleep.2026.109154_bib71","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2169\/internalmedicine.52.9179","article-title":"Use of ramelteon for the treatment of secondary REM sleep behavior disorder","volume":"52","author":"Nomura","year":"2013","journal-title":"Intern Med"},{"issue":"5","key":"10.1016\/j.sleep.2026.109154_bib72","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.sleep.2006.03.018","article-title":"Use of pramipexole in REM sleep behavior disorder: results from a case series","volume":"7","author":"Schmidt","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2026.109154_bib73","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2015.2904","article-title":"A case of rapid eye movement sleep behavior disorder in Parkinson disease treated with sodium oxybate","author":"Liebenthal","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.sleep.2026.109154_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2016.04.014","article-title":"Sodium oxybate for idiopathic REM sleep behavior disorder: a report on two patients","author":"Moghadam","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2026.109154_bib75","article-title":"Safinamide effect on sleep architecture of motor fluctuating Parkinson's disease patients: a polysomnographic rasagiline-controlled study","volume":"127","author":"Bovenzi","year":"2024","journal-title":"Parkinsonism Relat Disorders"},{"issue":"5","key":"10.1016\/j.sleep.2026.109154_bib76","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/JCP.0b013e31826866f8","article-title":"Agomelatine may improve REM sleep behavior disorder symptoms","volume":"32","author":"Bonakis","year":"2012","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"10.1016\/j.sleep.2026.109154_bib77","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.pnpbp.2008.06.015","article-title":"Successful treatment with Yi-Gan San for rapid eye movement sleep behavior disorder","volume":"32","author":"Shinno","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.sleep.2026.109154_bib78","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/psyg.12563","article-title":"Efficacy of yokukansan compared with clonazepam for rapid eye movement sleep behaviour disorder: a preliminary retrospective study","volume":"20","author":"Ozone","year":"2020","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.sleep.2026.109154_bib79","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-025-04451-7","article-title":"Acetyl-DL-leucine (Tanganil\u2122) in three patients with advanced multiple system atrophy","author":"Oertel","year":"2025","journal-title":"BMC Neurol"},{"key":"10.1016\/j.sleep.2026.109154_bib80","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-025-13195-w","article-title":"\u201cHow to save a marriage\u201d: treatment of REM sleep behavior disorder (RBD) with acetyl-leucine in a patient with Parkinson's disease","author":"Oertel","year":"2025","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2026.109154_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-51502-7","article-title":"Acetyl-DL-leucine in two individuals with REM sleep behavior disorder improves symptoms, reverses loss of striatal dopamine-transporter binding and stabilizes pathological metabolic brain pattern: case reports","author":"Oertel","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.sleep.2026.109154_bib82","first-page":"101","article-title":"Activation by selegiline (Eldepryle) of REM sleep behavior disorder in parkinsonism","volume":"91","author":"Louden","year":"1995","journal-title":"W Va Med J"},{"issue":"10","key":"10.1016\/j.sleep.2026.109154_bib83","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/gps.2506","article-title":"The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia","volume":"25","author":"Larsson","year":"2010","journal-title":"Int J Geriatr Psychiatr"},{"issue":"2","key":"10.1016\/j.sleep.2026.109154_bib84","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/mds.870110216","article-title":"Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa","volume":"11","author":"Tan","year":"1996","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.sleep.2026.109154_bib85","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0163-8343(03)00003-3","article-title":"Levodopa improved rapid eye movement sleep behavior disorder with diffuse Lewy body disease","volume":"25","author":"Yamauchi","year":"2003","journal-title":"Gen Hosp Psychiatry"},{"issue":"10","key":"10.1016\/j.sleep.2026.109154_bib86","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1007\/s00415-020-09956-4","article-title":"Association between dopaminergic medications and REM sleep behavior disorder in Parkinson's disease: a preliminary cohort study","volume":"267","author":"Meloni","year":"2020","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.sleep.2026.109154_bib87","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00415-017-8491-2","article-title":"A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion","volume":"264","author":"Zibetti","year":"2017","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.sleep.2026.109154_bib88","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2169\/internalmedicine.55.5464","article-title":"Beneficial effects of ramelteon on rapid eye movement sleep behavior disorder associated with Parkinson's disease: results of a multicenter open trial","volume":"55","author":"Kashihara","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.sleep.2026.109154_bib89","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis"},{"issue":"17","key":"10.1016\/j.sleep.2026.109154_bib90","doi-asserted-by":"crossref","first-page":"9197","DOI":"10.3390\/ijms25179197","article-title":"The role of \u03b1-synuclein in etiology of neurodegenerative diseases","volume":"25","author":"Krawczuk","year":"2024","journal-title":"Int J Mol Sci"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138994572600393X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138994572600393X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:21:54Z","timestamp":1791087714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138994572600393X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":90,"alternative-id":["S138994572600393X"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2026.109154","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological treatments of REM sleep behaviour disorder in synucleinopathies: a systematic review of effectiveness and safety","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2026.109154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109154"}}